Q3 2025: Encouraging volume momentum overshadows FX headwinds
07/11/25 -"Novonesis delivered a good Q3 2025, with revenue and adjusted EBITDA beating consensus. Organic sales growth of 6% was driven by broad-based volume strength. Regionally, emerging markets stood out ..."
Pages
55
Language
English
Published on
07/11/25
You may also be interested by these reports :
07/11/25
All segments performed decently in Q3, though the markets were spooked by Hikma’s mid-term outlook downgrade. Operational delays at the Bedford ...
07/11/25
Novonesis delivered a good Q3 2025, with revenue and adjusted EBITDA beating consensus. Organic sales growth of 6% was driven by broad-based volume ...
06/11/25
The Q3 results surpassed expectations, backed by strong performance from Oncology, Respiratory & Immunology, and Rare Disease medicines. Now, the ...
06/11/25
The Q3 profits were ahead of consensus and, consequently, the management upgraded its 2025 guidance at February 2025 FX rates. However, FX headwinds ...